FIGURE

Fig. 7

ID
ZDB-FIG-220818-10
Publication
Volpatti et al., 2022 - X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition
Other Figures
All Figure Page
Back to All Figure Page
Fig. 7

VPA rescues differentiation arrest and ?1-integrin alterations in Mtm1-KO myotubes. a Brightfield of MHC and DAPI staining of differentiated C2C12 myotubes (D10) showing that VPA rescues the aberrant differentiation and reduced size observed in Mtm1-KO cells. Scale bars, 100 ?m. a?c are higher magnifications of the indicated areas shown as boxes. b Average area of MHC labeled WT, Mtm1-KO and Mtm1-KO VPA-treated cells after 10 days of differentiation. Data are represented as Mean?±?SEM, n?=?5, 5 fields per independent experiment, each point represents one field of view, ****p?<?0.0001 and **p?<?0.01, one-way ANOVA test and ?ídák's multiple comparisons test. c Relative directionality of WT, Mtm1-KO and Mtm1-KO VPA-treated cells after 10 days of differentiation. Data are represented as Mean?±?SEM, n?=?5 fields per independent experiment, each point represents one field of view, ns?not significant and ****p?<?0.0001, one-way ANOVA test and ?ídák's multiple comparisons test. d BioID workflow for the identification of an MTM1 interactome. e MHC staining of WT, Mtm1-KO and Mtm1-KO expressing MTM1-miniTurbo-flag myotubes after the indicated days of differentiation, showing that miniTurbo does not affect MTM1 function. Scale bar, 100 ?m. f Identification of candidate interactors by quantitative mass spectrometry. Volcano plot depicting quantified proteins (gene names). The x axis shows the average fold change (log2) in protein abundance in MTM1-miniTurbo samples in comparison to miniTurbo controls, and the y axis shows the ?log10 (p value); data for both were determined by results from three independent experiments. Significantly enriched proteins in the MTM1-miniTurbo condition are displayed in orange, MTM1 bait protein displayed in blue, and known MTM1 partners in green. Proteins (gene names) related to ?1-integrin trafficking in purple. g Enrichment (abundance ratios as log2 values (MTM1-miniTurbo?miniTurbo)) of peptides from three independent experiments (mean) related to MTM1 and ?1-integrin trafficking. h Top: expression of ?1-integrin in WT and Mtm1-KO C2C12 cells at the indicated differentiation time points (n?=?3 independent experiments). Bottom: quantification of ?1-integrin expression analyzed by Western. Data are represented as Mean?±?SEM, n?=?3, *p?<?0.05 and **p?<?0.01 according to Student?s t test. i Top: expression of ?1-integrin of WT, Mtm1-KO, Mtm1-KO VPA-treated C2C12 cells after 10 days of differentiation (n?=?3 independent experiments). Bottom: quantification of ?1-integrin expression. ns?not significant and **p?<?0.01 according to Student?s t test. j Top: expression of Talin1 of WT, Mtm1-KO, Mtm1-KO VPA-treated C2C12 cells after 10 days of differentiation (n?=?3 independent experiments). Bottom: quantification of Talin expression. ns?not significant and **p?<?0.01 according to Student?s t test. Top: representative confocal images of ?1-integrin distribution from 10-days differentiated WT (k), Mtm1-KO (l) and Mtm1-KO C2C12 myotubes?±?250 µM VPA (m). Scale bar, 10 ?m. Bottom: higher magnifications of the boxed area shown on the top. Scale bar, 5 ?m. n Quantification of ?1-integrin vesicles density (Mean?±?SEM, n?=?3, 5 fields per independent experiment, each point represents one field of view, ****p?<?0.0001 according to one-way ANOVA test and ?ídák's multiple comparisons test

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Neuropathol.